PubRank

Shuichi Seki

Author PubWeight™ 34.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus. Am J Gastroenterol 2005 1.72
2 Homozygous deletion scanning in hepatobiliary tumor cell lines reveals alternative pathways for liver carcinogenesis. Hepatology 2003 1.70
3 Cytoglobin/STAP, its unique localization in splanchnic fibroblast-like cells and function in organ fibrogenesis. Lab Invest 2004 1.38
4 Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers. Oncogene 2004 1.27
5 Stimulation of proliferation of rat hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways. J Biol Chem 2003 1.13
6 Detection of serum hepatitis B virus DNA by real-time quantitative polymerase chain reaction (TaqMan PCR) during lamivudine treatment: comparison with three other assays. Hepatol Res 2003 1.11
7 Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats. J Hepatol 2004 1.01
8 Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J Gastroenterol 2006 0.98
9 Asymptomatic chronic intestinal ischemia caused by idiopathic phlebosclerosis of mesenteric vein. Dig Dis Sci 2002 0.97
10 Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study. Hepatol Res 2006 0.94
11 Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences. J Med Virol 2007 0.92
12 Characterization of human stellate cell activation-associated protein and its expression in human liver. Biochim Biophys Acta 2002 0.92
13 Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer. Int J Cancer 2002 0.89
14 Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon-alpha2b and ribavirin therapy in patients with genotype 1 and high viral loads. J Med Virol 2005 0.88
15 Regulation of cultured rat hepatocyte proliferation by stellate cells. J Hepatol 2002 0.88
16 Expression of SPARC by activated hepatic stellate cells and its correlation with the stages of fibrogenesis in human chronic hepatitis. Virchows Arch 2002 0.87
17 High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice. Cancer Lett 2006 0.86
18 Involvement of Galectin-1 and Galectin-3 in Proliferation and Migration of Rat Hepatic Stellate Cells in Culture. Comp Hepatol 2004 0.85
19 Apoptosis of T cells in the hepatic fibrotic tissue of the rat: a possible inducing role of hepatic myofibroblast-like cells. Cell Tissue Res 2003 0.85
20 Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers. J Med Virol 2005 0.84
21 Pit cells as liver-associated natural killer cells: morphology and function. Med Electron Microsc 2004 0.83
22 Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C. Hepatogastroenterology 2003 0.83
23 Portal vein thrombosis following percutaneous ethanol injection therapy for hepatocellular carcinoma. Indian J Gastroenterol 2002 0.82
24 Endoscopic thermal ablation therapies for hepatocellular carcinoma: a multi-center study. Hepatol Res 2008 0.81
25 Pepstatin A attenuates the inhibitory effect of N-acetyl-L-cysteine on proliferation of hepatic myofibroblasts (stellate cells). Eur J Pharmacol 2002 0.81
26 Cyclooxygenase-2 expression in the adenoma-carcinoma sequence of human gallbladder. Am J Gastroenterol 2002 0.80
27 Negative hMSH2 protein expression in pancreatic carcinoma may predict a better prognosis of patients. Oncol Rep 2003 0.80
28 Expression of NCAM in activated portal fibroblasts during regeneration of the rat liver after partial hepatectomy. Arch Histol Cytol 2006 0.78
29 Mode of HCV infection examined by polymorphism of hypervariable region-1 in cases of acute hepatitis C after accidental exposure to blood-borne pathogens. J Med Virol 2005 0.77
30 Lamivudine and IFN-beta sequential therapy in HBe antigen-positive patients with chronic hepatitis B virus genotype C infection. J Interferon Cytokine Res 2007 0.77
31 Resection of needle-tract implantation after percutaneous puncture for hepatocellular carcinoma. J Gastroenterol 2004 0.77
32 Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection? Hepatol Res 2006 0.77
33 A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide/d-galactosamine. Virchows Arch 2005 0.77
34 Very low incidence of microsatellite instability in intraductal papillary-mucinous neoplasm of the pancreas. Int J Cancer 2002 0.77
35 Enhancement by estradiol 3-benzoate in thioacetamide-induced liver cirrhosis of rats. Toxicol Sci 2005 0.77
36 Role of oxidative DNA damage caused by carbon tetrachloride-induced liver injury -- enhancement of MeIQ-induced glutathione S-transferase placental form-positive foci in rats. Cancer Lett 2002 0.76
37 Cimetidine reduces impairment of cellular immunity after transcatheter arterial embolization in patients with hepatocellular carcinoma. Hepatogastroenterology 2003 0.76
38 Suppression of Rat Stellate Cell Activation and Liver Fibrosis by a Japanese Herbal Medicine, Inchinko-to (TJ135). Comp Hepatol 2004 0.76
39 Does a late evening meal reduce the risk of hepatocellular carcinoma among patients with chronic hepatitis C? Hepatol Res 2008 0.75
40 Three cases of primary sclerosing cholangitis associated with ulcerative colitis; diagnostic usefulness of magnetic resonance cholangiopancreatography. Hepatogastroenterology 2002 0.75
41 Localization of lymphocyte apoptosis in murine lymphoid tissues after stimulation of natural killer T cells with alpha-galactosylceramide. Arch Histol Cytol 2003 0.75
42 Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma. Am J Gastroenterol 2004 0.75
43 Laparoscopic observation of 2 cases of nodular regenerative hyperplasia of the liver. Gastrointest Endosc 2007 0.75
44 Gastric ulcer as a rare complication of percutaneous ethanol injection for hepatocellular carcinoma. Am J Gastroenterol 2002 0.75
45 Comparison of outcomes using the sirolimus-eluting stent in calcified versus non-calcified native coronary lesions in patients on- versus not on-chronic hemodialysis (from the j-Cypher registry). Am J Cardiol 2013 0.75
46 Sporadic intra-abdominal desmoid with acute abdomen. Indian J Gastroenterol 2002 0.75
47 Portal hemodynamics in primary biliary cirrhosis as evaluated by per-rectal portal scintigraphy with Tc-99m pertechnetate. Hepatogastroenterology 2003 0.75
48 Ultrasonographic diagnosis of degree of chronic type C liver disease. Hepatogastroenterology 2005 0.75
49 Does colitis associated with primary sclerosing cholangitis represent an actual subset of ulcerative colitis? Hepatogastroenterology 2003 0.75